OC Independent: Free Memory Screening In Brea For Over-50 On Thursday, May 16 

/

By:OCI Staff Syrentis Clinical Research will hold a free memory screening event on Thursday, May 16 for people aged 50 and above to increase awareness for early detection of memory loss and Alzheimer’s disease. In California, it is estimated that more than 690,000 people are currently living with Alzheimer’s Disease, and experts predict that this […]

Read more »

Community Newspapers: Aventura Mother and Award-Winning Volunteer Celebrated by Local Researchers for Outstanding Volunteerism

/

By  Community News Releases, May 9, 2024 Visionary Investigators Network honored Joanne Bridges, the recipient of the 2023 National Citizen Scientist Collaborator Award® to recognize her extraordinary efforts as a study partner in an Alzheimer’s clinical trial at  Visionary Investigators Network. The Aventura mother and resident was selected as a National Honoree for the Global Alzheimer’s Platform Foundation® (GAP) Collaborator Award, from a […]

Read more »

Pink Sheet: Medicare Spending Forecast For Leqembi Reflects CMS Angst About Alzheimer’s Drug Costs

/

by Cathy Kelly, April 15, 2025 The agency’s projection that Medicare will spend $3.5bn on Leqembi in 2025 is nearly three times the level of sales that marketer Eisai is expecting for the drug in North and South America combined in its fiscal year 2026. The Centers for Medicare and Medicaid Services appear to be […]

Read more »

TrialSiteNews: Florida Trial Site Contributes to Successful Study Testing Alzheimer’s Blood Test, Now on Market for Research, Physicians

/

trialsitenews Staff at TrialSite | Quality Journalism Apr. 12, 2024, 1:00 p.m. Expensive and not always covered by insurance, the standard most reliable method of diagnosing Alzheimer’s disease is via positron emission tomography or PET scan of the brain. Another more cumbersome, invasive and painful approach is the spinal tap. What if there was an […]

Read more »

Bravo Column: Orange County resident awarded for advancing Alzheimer’s research

Costa Mesa resident Jeannie Weiss is driving Alzheimer’s research forward and is receiving a national award for her exemplary volunteerism to help advance science. The Global Alzheimer’s Platform Foundation (GAP) recognized Weiss for her exceptional role in Alzheimer’s research. Weiss received GAP’s 2023 National Citizen Scientist Champion Award, which is given to individuals who act […]

Read more »

NHS Research Scotland: Scotland proud to host first-of-its-kind Alzheimer’s research challenge

/

28th March 2024 Scotland has been selected to host a first-of-its-kind Alzheimer’s research competition, representing ‘significant recognition of the country’s wealth of world-leading expertise,’ says the Chief Scientist for Health Professor Anna Dominiczak welcomed the news that Scotland has already launched the Bio-Hermes Biomarker Data Challenge, granting access to what has been called “the most comprehensive […]

Read more »

Biopharma Boardroom: Scotland to Host Research Challenge Using the Most Comprehensive Set of Dementia Biomarker Data in the World

The Global Alzheimer’s Platform Foundation® (GAP) has announced that Scotland will host the Bio-Hermes Biomarker Data Challenge 2024, a groundbreaking research competition utilizing the most extensive collection of dementia biomarker data from innovative early blood testing studies for Alzheimer’s disease. Researchers at the Universities of Glasgow and St. Andrews, under the auspices of the Scottish […]

Read more »

Scotland to host research challenge using the most comprehensive set of dementia biomarker in the world

/

Washington D.C., Mar. 25, 2024- The Global Alzheimer’s Platform Foundation® (GAP) – which is focused on global game-changing dementia research – has chosen Scotland to host the Bio-Hermes Biomarker Data Challenge 2024, a research competition using the most comprehensive set of dementia biomarker data from ground-breaking early blood testing studies for Alzheimer’s disease. Researchers at […]

Read more »

Global Alzheimer’s Platform Foundation Applauds Labcorp’s Expansion of Alzheimer’s Blood Tests

/

Washington D.C., Mar. 20, 2024- Labcorp announced its launch of new blood tests to detect the brain protein called tau. This announcement comes on the heels of the published results of the Bio-Hermes-001 study  which reveals a strong correlation between p-tau 217 with the presence of amyloid plaques in the brain, a diagnostic hallmark of […]

Read more »

WMNF: Study could bring more affordable Alzheimer’s detection

/

POSTED ON MARCH 19, 2024BY CHRIS YOUNG It’s estimated over 580 thousand Floridians are living with Alzheimer’s disease. A study could lead to a simpler way to detect the disease. The study, called Bio-Hermes, showed how new Alzheimer’s detecting blood tests perform across a broad range of races and ethnicities for the first time. Currently, scans or spinal taps […]

Read more »

New Santa Ana: O.C. Mustang enthusiast honored for her role in Alzheimer’s research

By Editor,  MAR 16, 2024 WASHINGTON, DC (Feb. 19, 2024) — Today, the Global Alzheimer’s Platform Foundation (GAP) recognized Orange County resident Jeannie Weiss for her exceptional role in Alzheimer’s research. Jeannie Weiss received GAP’s 2023 National Citizen Scientist Champion Award®, which is given to individuals who act as a stimulus in bringing new, novel approaches to Alzheimer’s research […]

Read more »

PINK SHEET: Lilly Pre-Approval Spadework Includes Alzheimer’s Blood Test Development, Unbranded DTC Ads

/

08 Mar 2024 ANALYSIS by Cathy Kelly; catherine.kelly@citeline.comExecutive Summary Donanemab’s review delay will create more distance from Lilly’s direct-to-consumer advertising spotlighting its commitment to Alzheimer’s research. The company has also been supporting development of blood-based tools for early diagnoses, though they would not eliminate PET scans. Eli Lilly and Company launched unbranded direct-to-consumer TV advertising […]

Read more »

Medical News Today: Could a simple blood test eventually diagnose Alzheimer’s?

/

By Katharine Lang on March 4, 2024 — Fact checked by Amanda WardA simple blood test, may in the future, help diagnose Alzheimer’s early. Image credit: Oleksii Syrotkin/Stocksy. Dementia currently affects around 60 millionTrusted Source people worldwide, and the number is projected to rise to more than 150 million by 2050. Alzheimer’s disease, the most common form of dementia, causes 60-80% of cases. Available treatments […]

Read more »

Community Newspapers: Miami Caregiver awarded prestigious honor for volunteerism in Alzheimer’s research

/

By  Community News Releases  -March 2, 2024 The Global Alzheimer’s Platform Foundation (GAP) recently recognized Miami resident Joanne Bridges with the 2023 National Citizen Scientist Collaborator Award. Bridges was selected from a pool of nominees from across North America to receive elevated recognition and be honored for supporting a clinical trial volunteer by serving as […]

Read more »

LabMedica: New Alzheimer’s Detecting Blood Tests Perform across Broad Range of Races and Ethnicities

/

By LabMedica International staff writersPosted on 29 Feb 2024      Alzheimer’s disease, which traditionally requires costly scans or invasive spinal taps for diagnosis, is now closer to being more easily identified through innovative blood tests. This advancement is particularly crucial with the recent approval of disease-modifying treatments for Alzheimer’s. Now, the results of a study […]

Read more »

Precision Medicine Online: Blood-Based Tests for Alzheimer’s Biomarkers Tau, Beta-Amyloid Prove Promising in Bio-Hermes Study

/

Feb 28, 2024 | Jessica Kim Cohen NEW YORK – Results from blood-based biomarker tests correlated with the presence of beta-amyloid detected using established Alzheimer’s disease diagnostics, according to a study published Wednesday. PET scans and cerebrospinal fluid (CSF) analyses are highly accurate and established methods of identifying elevated levels of beta-amyloid, a hallmark of Alzheimer’s. However, these […]

Read more »

Promising Pathways to Simplified Alzheimer’s Diagnosis Unveiled in Groundbreaking Study

/

The results of the Bio-Hermes study appear in Alzheimer’s & Dementia showing how new Alzheimer’s detecting blood tests perform across a broad range of races and ethnicities for the first time. Washington D.C., Feb. 28, 2024- The Global Alzheimer’s Platform Foundation®, (GAP) is releasing the first results from the Bio-Hermes-001 Study. This study in over […]

Read more »

Investors Meet Opportunity at Inaugural Global Alzheimer’s Platform Foundation Innovation Summit

/

At a pivotal time in Alzheimer’s research, the GAP Foundation and the Alzheimer’s Drug Discovery Foundation will connect funders with leading innovators Updated on March 26, 2020: The Global Alzheimer’s Platform Foundation (GAP) has announced it is postponing the GAP Innovation Summit that was to be held on May 5, 2020 with our partner, the […]

Read more »

A Meeting of the Minds

/

For the first time in 15 years, there are new Alzheimer’s drug treatments on the horizon that are expected to seek regulatory approval by the FDA and leading experts are increasely optimistic that a major breakthrough in Alzheimer’s research will occur within the next five years. We are at a moment of peak opportunity – […]

Read more »
To top